A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult Subjects
Clinical trial NCT04196101 · COMPLETED
Trial details
- NCT number
- NCT04196101
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-22
- Primary completion
- 2022-01-04
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.